Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Abroad (travel likely)Recruiting
Conditions
Ventricular Tachycardia (VT)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Andre d'Avila, MD)Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Principal Investigator (Srinivas Dukkipati, MD)Cleveland Clinic Foundation, Cleveland, Ohio, United States
Contact: Principal Investigator (Pasquale Santangeli, MD)Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Francis Marchlinski, MD)Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Principal Investigator (William Stevenson, MD)Texas Cardiac Arrhythmia Research Foundation, Austin, Texas, United States
Contact: Principal Investigator (John David Burkhardt, MD)
Study leads
Vivek Reddy, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai